A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease

A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 223 participants.

Also called NCT04881448

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Phase 2
Enrolled
  • 223 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04881448
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Germany, Hungary, Spain (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT04881448. Allocation not applicable; no masking; primary purpose diagnostic. Start 2021-09-16 (actual); primary completion 2022-07-15 (actual). Results posted on 2023-08-04.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease
Intervention (Diagnostic test)
collection of serum/capillary creatinine values
Lead sponsor
Boehringer Ingelheim (class: industry)

Record details

Record id
cardio:ct-nct04881448
Content hash
c30707768baa647c253587ec97e927b5ec5699863b9da909a7fc315ae016bfb5